Abrégé

The solid preparation contains: component (A): at least one selected from the group consisting of loxoprofen, salts thereof, and hydrates thereof; component (B): anhydrous calcium hydrogen phosphate; and component (C): granules containing silicon dioxide; and includes component (D): a disintegrant inside the granules and/or outside the granules.

Classes IPC  ?

• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 9/26 - Particules distinctes dans une matrice support
• A61K 31/195 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino
• A61K 47/02 - Composés inorganiques
• A61K 47/04 - Non-métauxLeurs composés
• A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
• A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
• A61K 47/38 - CelluloseSes dérivés
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Abrégé

The present invention provides a solid composition that contains: (a) bromhexine or a salt thereof; (b) a nonionic surfactant; and (c) a compound selected from the group consisting of a vitamin-based antioxidant, a phenolic antioxidant, meloxicam and acetaminophen (solid compositions containing ibuprofen, clemastine fumarate, dihydrocodeine phosphate, noscapin, dl-methylephedrine hydrochloride, anhydrous caffeine, bromhexine hydrochloride, tranexamic acid, riboflavin, benfotiamine, ascorbic acid, hesperidin, D-mannitol, low-substituted hydroxypropyl cellulose, crystalline cellulose, hydroxypropyl cellulose, polyoxyethylene hardened castor oil 60, hypromellose, talc, hydroxypropyl cellulose, and light anhydrous silicic acid are excluded).

Classes IPC  ?

• A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 31/167 - Amides, p. ex. acides hydroxamiques ayant des cycles aromatiques, p. ex. colchicine, aténolol, progabide ayant l'atome d'azote d'un groupe carboxamide lié directement au cycle aromatique, p. ex. lidocaïne, paracétamol
• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 31/196 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino le groupe amino étant lié directement à un cycle, p. ex. acide anthranilique, acide méfénamique, diclofénac, chlorambucil
• A61K 31/5415 - Composés hétérocycliques ayant l'azote comme hétéro-atome d'un cycle, p. ex. guanéthidine ou rifamycines ayant des cycles à six chaînons avec au moins un azote et au moins un soufre comme hétéro-atomes d'un cycle, p. ex. sulthiame condensés en ortho ou en péri avec des systèmes carbocycliques, p. ex. phénothiazine, chlorpromazine, piroxicam
• A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
• A61K 47/22 - Composés hétérocycliques, p. ex. acide ascorbique, tocophérol ou pyrrolidones
• A61K 47/26 - Hydrates de carbone, p. ex. polyols ou sucres alcoolisés, sucres aminés, acides nucléiques, mono-, di- ou oligosaccharidesLeurs dérivés, p. ex. polysorbates, esters d’acide gras de sorbitan ou glycyrrhizine
• A61P 11/10 - Expectorants
• A61P 11/14 - Antitussifs
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Abrégé

A method for producing a solid preparation according to the present invention is for producing a solid preparation which contains (A) at least one substance that is selected from the group consisting of loxoprofen, salts thereof, and hydrates of loxoprofen and the salts, and (B) at least one substance that is selected from the group consisting of tranexamic acid and salts thereof. The method includes a wet granulation step for obtaining granules by supplying water to a starting material powder that contains the components (A) and (B). In the wet granulation step, X is adjusted so as to satisfy 0.20 ≤ Ig ≤ 0.99, wherein X is the addition rate of water to be supplied, PL is the plastic limit water addition rate of the starting material powder, and Ig is the granulation index that is represented by X/PL.

Classes IPC  ?

• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
• A61K 31/195 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Abrégé

This skin-improving agent contains the following components (A) to (C). (A) At least one selected from the group consisting of L-cysteine, a derivative thereof and a salt thereof. (B) At least one selected from the group consisting of ascorbic acid, a derivative thereof, and a salt thereof. (C) One or more selected from the group consisting of vitamin B5, vitamin B6, vitamin B2, vitamin E, gamma oryzanol, dong quai and an extract thereof.

Classes IPC  ?

• A61K 31/375 - Acide ascorbique, c.-à-d. vitamine CSes sels
• A61K 8/44 - Acides aminocarboxyliques ou leurs dérivés, p. ex. acides aminocarboxyliques contenant du soufreLeurs sels, esters ou dérivés N-acylés
• A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
• A61K 8/63 - StéroïdesLeurs dérivés
• A61K 8/67 - Vitamines
• A61K 8/9789 - Magnoliopsida [dicotylédones]
• A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 31/355 - Tocophérols, p. ex. vitamine E
• A61K 31/4415 - Pyridoxine, c.-à-d. vitamine B6
• A61K 31/525 - Iso-alloxazines, p. ex. riboflavines, vitamine B2
• A61K 31/575 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes substitués en position 17 bêta par une chaîne d'au moins trois atomes de carbone, p. ex. cholane, cholestane, ergostérol, sitostérol
• A61K 36/232 - Angelica
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
• A61Q 19/00 - Préparations pour les soins de la peau
• A61Q 19/02 - Préparations pour les soins de la peau pour décolorer ou blanchir la peau chimiquement

Abrégé

Provided is a skin-improving agent comprising the component (A1) or (A2) and the component (B1) or (B2) mentioned below. (A1) At least one component selected from the group consisting of Japanese angelica root and an extract thereof; (A2) gamma oryzanol; (B1) one or more components selected from the group consisting of vitamin B5 compounds, vitamin B6 compounds, vitamin B2 compounds, vitamin B3 compounds, L-cysteine and derivatives thereof, and salts of L-cysteine and the derivatives, ascorbic acid and derivatives thereof, and salts of ascorbic acid and the derivatives, and vitamin E compounds; and (B2) one or more components selected from the group consisting of vitamin B5 compounds, vitamin B6 compounds, L-cysteine and derivatives thereof, and salts of L-cysteine and the derivatives, ascorbic acid and derivatives thereof, and salts of ascorbic acid and the derivatives, and vitamin B2 compounds.

Classes IPC  ?

• A61K 36/232 - Angelica
• A61K 8/44 - Acides aminocarboxyliques ou leurs dérivés, p. ex. acides aminocarboxyliques contenant du soufreLeurs sels, esters ou dérivés N-acylés
• A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
• A61K 8/63 - StéroïdesLeurs dérivés
• A61K 8/67 - Vitamines
• A61K 8/9789 - Magnoliopsida [dicotylédones]
• A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 31/355 - Tocophérols, p. ex. vitamine E
• A61K 31/375 - Acide ascorbique, c.-à-d. vitamine CSes sels
• A61K 31/455 - Acide nicotinique, c.-à-d. niacineSes dérivés, p. ex. esters, amides
• A61K 31/525 - Iso-alloxazines, p. ex. riboflavines, vitamine B2
• A61K 31/575 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes substitués en position 17 bêta par une chaîne d'au moins trois atomes de carbone, p. ex. cholane, cholestane, ergostérol, sitostérol
• A61K 31/4415 - Pyridoxine, c.-à-d. vitamine B6
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
• A61Q 19/00 - Préparations pour les soins de la peau
• A61Q 19/02 - Préparations pour les soins de la peau pour décolorer ou blanchir la peau chimiquement

Abrégé

This solid preparation contains component (A): at least one substance selected from the group consisting of loxoprofen, salts thereof, and hydrates thereof, and component (B): at least one substance selected from the group consisting of tranexamic acid and salts thereof, and is such that in an X-ray diffraction pattern measured using Cu-Kα rays, there is no peak in at least three of the following five ranges of diffraction angle 2θ: 7.3 ± 0.1, 11.0 ± 0.1, 19.1 ± 0.1, 22.2 ± 0.1, and 24.8 ± 0.1.

Classes IPC  ?

• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 31/195 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]

Abrégé

The present invention addresses the problem of providing a novel technology in which loxoprofen and/or a salt thereof are used to prevent pharyngitis and recover a water-swallowing reflex. The present invention provides a pharmaceutical composition which has a pharyngitis inhibitory action and which includes at least one selected from the group consisting of loxoprofen, salts thereof, and hydrates thereof.

Classes IPC  ?

• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61P 11/04 - Médicaments pour le traitement des troubles du système respiratoire des maux de gorge
• A61P 25/02 - Médicaments pour le traitement des troubles du système nerveux des neuropathies périphériques
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Abrégé

The present invention provides a skin quality improver containing Bacillus coagulans as an active ingredient (the skin quality improver excluding (1) and (2) below). (1) A beautifying food or beverage containing star fruit tea extract, Bacillus coagulans, fermented collagen peptides, vitamin C, and vitamin B6. (2) A beautifying food containing Bacillus coagulans, ceramides, and soybean peptides.

Classes IPC  ?

• A23L 33/135 - Bactéries ou leurs dérivés, p. ex. probiotiques
• A61K 8/99 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de micro-organismes autres que des algues ou des champignons, p. ex. à base de protozoaires ou de bactéries
• A61K 35/742 - Bactéries sporulées, p. ex. Bacillus coagulans, Bacillus subtilis, clostridium ou Lactobacillus sporogenes
• A61P 1/02 - Préparations stomatologiques, p. ex. médicaments pour le traitement des caries, des aphtes, des périodontites
• A61P 31/04 - Agents antibactériens
• A61Q 19/00 - Préparations pour les soins de la peau
• A61Q 19/08 - Préparations contre le vieillissement
• C12N 1/20 - BactériesLeurs milieux de culture

Abrégé

The present invention addresses the problem of providing an oral composition that has an excellent ability to form an effective bacterial flora in the oral cavity, is capable of preventing the occurrence of dental caries or periodontal disease caused by oral pathogens or capable of treating such a disease, and capable of also preventing or curing halitosis. The present invention provides an oral composition containing Lactobacillus sporogenes.

Classes IPC  ?

• A61K 8/99 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des produits de constitution indéterminée ou leurs dérivés à base de micro-organismes autres que des algues ou des champignons, p. ex. à base de protozoaires ou de bactéries
• A61K 35/744 - Bactéries lactiques, p. ex. entérocoques, pédiocoques, lactocoques, streptocoques ou leuconostoques
• A61P 1/02 - Préparations stomatologiques, p. ex. médicaments pour le traitement des caries, des aphtes, des périodontites
• A61Q 11/00 - Préparations pour le nettoyage des dents, de la bouche ou des prothèses dentaires, p. ex. dentifricesBains de bouche
• C12N 1/20 - BactériesLeurs milieux de culture

Abrégé

The present invention provides a solid composition containing nicotinamide, ascorbic acid, tranexamic acid, and L-cysteine.

Classes IPC  ?

• A61K 31/455 - Acide nicotinique, c.-à-d. niacineSes dérivés, p. ex. esters, amides
• A23L 5/00 - Préparation ou traitement des aliments ou produits alimentaires en généralAliments ou produits alimentaires ainsi obtenusLeurs matériaux
• A23L 33/15 - Vitamines
• A23L 33/175 - Acides aminés
• A61K 8/44 - Acides aminocarboxyliques ou leurs dérivés, p. ex. acides aminocarboxyliques contenant du soufreLeurs sels, esters ou dérivés N-acylés
• A61K 8/49 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques contenant des composés hétérocycliques
• A61K 8/67 - Vitamines
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 9/28 - DragéesPilules ou comprimés avec revêtements
• A61K 31/195 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 31/375 - Acide ascorbique, c.-à-d. vitamine CSes sels
• A61K 47/20 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite contenant du soufre, p. ex. sulfoxyde de diméthyle [DMSO], docusate, laurylsulfate de sodium ou acides aminosulfoniques
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
• A61P 17/18 - Antioxydants, p. ex. antiradicaux
• A61P 39/06 - Antiradicaux libres ou antioxydants
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes
• A61Q 19/00 - Préparations pour les soins de la peau

Abrégé

This liquid composition for oral use comprises component (a), which is at least one selected from the group consisting of tranexamic acid and salts thereof, and a component (b), which is a perfume, and fulfils at least one of conditions 1 and 2 below. Condition 1 is that the liquid composition further comprises a component (c), which is a surfactant having an HLB value of 13.0-20.0, where the mass ratio (c)/((a)+(b)) is at least 3.5. Condition 2 is that the color difference ΔE* is 0.0-2.5.

Classes IPC  ?

• A61K 8/44 - Acides aminocarboxyliques ou leurs dérivés, p. ex. acides aminocarboxyliques contenant du soufreLeurs sels, esters ou dérivés N-acylés
• A61K 8/02 - Cosmétiques ou préparations similaires pour la toilette caractérisés par une forme physique particulière
• A61K 8/19 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés inorganiques
• A61Q 11/00 - Préparations pour le nettoyage des dents, de la bouche ou des prothèses dentaires, p. ex. dentifricesBains de bouche

Abrégé

Provided is a loxoprofen-containing solid preparation for external use, that is excellent in solubility during production. The present invention provides a solid preparation for external use containing: loxoprofen, at least one selected from the group consisting of salts thereof and hydrates thereof, a saturated fatty acid salt, a polyoxyethylene-cured castor oil, and a polyethylene glycol fatty acid ester.

Classes IPC  ?

• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 9/06 - OnguentsExcipients pour ceux-ci
• A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
• A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides
• A61K 47/14 - Esters d’acides carboxyliques, p. ex. acides gras monoglycérides, triglycérides à chaine moyenne, parabènes ou esters d’acide gras de PEG
• A61K 47/22 - Composés hétérocycliques, p. ex. acide ascorbique, tocophérol ou pyrrolidones
• A61K 47/44 - Huiles, graisses ou cires couvertes par plus d’un des groupes Huiles, graisses ou cires naturelles ou naturelles modifiées, p. ex. huile de ricin, huile de ricin polyéthoxylée, cire de lignite, lignite, gomme-laque, colophane, cire d’abeille ou lanoline
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]

Abrégé

The present invention addresses the problem of providing a skin external preparation, that contains a heparinoid and at least one selected from the group consisting of loxoprofen, a salt thereof and hydrates of the same, and that has improved stability. According to the present invention, provided is a skin external preparation that contains a heparinoid and at least one selected from the group consisting of loxoprofen, a salt thereof and hydrates of the same and that has excellent stability.

Classes IPC  ?

• A61K 31/727 - HéparineHéparane
• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 31/737 - Polysaccharides sulfatés, p. ex. sulfate de chondroïtine, sulfate de dermatane
• A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
• A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides
• A61K 47/18 - AminesAmidesUréesComposés d’ammonium quaternaireAcides aminésOligopeptides ayant jusqu’à cinq acides aminés
• A61K 47/22 - Composés hétérocycliques, p. ex. acide ascorbique, tocophérol ou pyrrolidones
• A61P 7/00 - Médicaments pour le traitement des troubles du sang ou du fluide extracellulaire
• A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
• A61P 9/14 - VasoprotecteursAntihémorroïdauxMédicaments pour le traitement des varicesStabilisateurs capillaires
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
• A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
• A61P 17/16 - Émollients ou protecteurs, p. ex. contre les radiations
• A61P 19/02 - Médicaments pour le traitement des troubles du squelette des troubles articulaires, p. ex. arthrites, arthroses
• A61P 19/04 - Médicaments pour le traitement des troubles du squelette des troubles non-spécifiques du tissu conjonctif
• A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Abrégé

The present invention addresses the problem of providing: a solid preparation obtained by blending an antacid and one or more types of compound selected from the group consisting of loxoprofen and a salt thereof, said preparation being a stable preparation in which a decrease in the loxoprofen content therein is suppressed; and a method for producing the same. The present invention provides a solid preparation which contains: one or more types of compound selected from the group consisting of loxoprofen and a salt thereof; a compound containing magnesium and/or aluminum; and a hydroxypropyl cellulose.

Classes IPC  ?

• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 9/14 - Préparations médicinales caractérisées par un aspect particulier à l'état particulaire, p. ex. poudres
• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 45/00 - Préparations médicinales contenant des ingrédients actifs non prévus dans les groupes
• A61K 47/02 - Composés inorganiques
• A61K 47/38 - CelluloseSes dérivés
• A61P 1/04 - Médicaments pour le traitement des troubles du tractus alimentaire ou de l'appareil digestif des ulcères, des gastrites ou des œsophagites par reflux, p. ex. antiacides, antisécrétoires, protecteurs de la muqueuse
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]

Abrégé

Provided is a liquid composition for oral use, which contains a water-soluble copper salt and a water-soluble aluminum salt.

Classes IPC  ?

• A61K 8/365 - Acides hydroxycarboxyliquesAcides cétocarboxyliques
• A61K 8/19 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés inorganiques
• A61K 8/26 - AluminiumSes composés
• A61Q 11/00 - Préparations pour le nettoyage des dents, de la bouche ou des prothèses dentaires, p. ex. dentifricesBains de bouche

Abrégé

The present invention provides a solid composition comprising nicotinic acid amide, ascorbic acid, and tranexamic acid.

Classes IPC  ?

• A61K 31/445 - Pipéridines non condensées, p. ex. pipérocaïne
• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 9/28 - DragéesPilules ou comprimés avec revêtements
• A61K 31/375 - Acide ascorbique, c.-à-d. vitamine CSes sels
• A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
• A61K 47/18 - AminesAmidesUréesComposés d’ammonium quaternaireAcides aminésOligopeptides ayant jusqu’à cinq acides aminés
• A61K 47/36 - PolysaccharidesLeurs dérivés, p. ex. gommes, amidon, alginate, dextrine, acide hyaluronique, chitosane, inuline, agar-agar ou pectine
• A61K 47/38 - CelluloseSes dérivés
• A61P 3/02 - Nutriments, p. ex. vitamines, minéraux
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Abrégé

To provide an exceptionally transparent composition in which cholesterol can be stably dispersed in an aqueous medium.　Provided is a transparent aqueous composition containing (a) cholesterol, (b) a surfactant having a sterol skeleton, and (c) water, the mass ratio ((b) surfactant having sterol skeleton/(a) cholesterol) of the (b) surfactant having a sterol skeleton to the (a) cholesterol being 4 or greater.

Classes IPC  ?

• A61K 8/63 - StéroïdesLeurs dérivés
• A61K 8/02 - Cosmétiques ou préparations similaires pour la toilette caractérisés par une forme physique particulière
• A61K 8/34 - Alcools
• A61K 8/86 - Polyéthers
• A61Q 19/00 - Préparations pour les soins de la peau

Abrégé

The present invention addresses the problem of providing a topical skin agent containing a heparinoid and another active ingredient, wherein the storage stability of the heparinoid is improved. According to the present invention, there is provided a topical skin agent containing a heparinoid and loxoprofen or a salt thereof.

Classes IPC  ?

• A61K 31/727 - HéparineHéparane
• A61K 9/06 - OnguentsExcipients pour ceux-ci
• A61K 9/08 - Solutions
• A61K 9/70 - Bases pour bande, feuille ou filament
• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
• A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides
• A61P 9/00 - Médicaments pour le traitement des troubles du système cardiovasculaire
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
• A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires
• A61P 19/02 - Médicaments pour le traitement des troubles du squelette des troubles articulaires, p. ex. arthrites, arthroses
• A61P 19/04 - Médicaments pour le traitement des troubles du squelette des troubles non-spécifiques du tissu conjonctif
• A61P 21/00 - Médicaments pour le traitement des troubles du système musculaire ou neuromusculaire
• A61P 29/00 - Agents analgésiques, antipyrétiques ou anti-inflammatoires non centraux, p. ex. agents antirhumatismauxMédicaments anti-inflammatoires non stéroïdiens [AINS]
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Abrégé

A multipurpose dryer according to an embodiment of the present disclosure allows free use of both hands during drying by adjusting the direction of a nozzle. The multipurpose dryer includes a body part including a blower inside to suck outdoor air, heat or cool it and force the heated or cooled air, and a manipulation panel outside to control the blower, a hose part including a first hose capable of freely bending and maintaining a deformed shape with one end coupled to the body part and the other end formed as a free end, and a second hose capable of freely bending and positioned inside the first hose, with one end coupled to the blower and the other end formed as a free end, and a nozzle part coupled to the other end of the second hose to spray the hot or cold air supplied from the blower.

Classes IPC  ?

• F26B 21/00 - Dispositions pour l'alimentation ou le réglage de l'air ou des gaz pour le séchage d'un matériau solide ou d'objets

Abrégé

Provided is an oil-in-water emulsion composition having excellent storage stability.　The present invention provides an oil-in-water emulsion composition containing: an oily component that contains (a1) cholesterol, (a2) a higher alcohol, and (a3) a hydrocarbon; a surfactant that contains (b1) polyoxyethylene alkyl ether; and an aqueous component, wherein the content of the component (a1) is 0.7-14 mass% of the total mass of the oily component, and the content of the component (b1) is 0.6-2.8 mass% of the total mass of the emulsion composition.

Classes IPC  ?

• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques
• A61Q 19/00 - Préparations pour les soins de la peau
• A61K 9/107 - Émulsions
• A61K 8/06 - Émulsions
• A61K 8/31 - Hydrocarbures
• A61K 8/34 - Alcools
• A61K 8/37 - Esters d'acides carboxyliques
• A61K 8/63 - StéroïdesLeurs dérivés
• A61K 8/81 - Cosmétiques ou préparations similaires pour la toilette caractérisés par la composition contenant des composés organiques macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons insaturées carbone-carbone
• A61K 8/86 - Polyéthers
• A61K 47/06 - Composés organiques, p. ex. hydrocarbures naturels ou synthétiques, polyoléfines, huile minérale, gelée de pétrole ou ozocérite
• A61K 47/10 - AlcoolsPhénolsLeurs sels, p. ex. glycérolPolyéthylène glycols [PEG]PoloxamèresAlkyléthers de PEG/POE
• A61K 47/14 - Esters d’acides carboxyliques, p. ex. acides gras monoglycérides, triglycérides à chaine moyenne, parabènes ou esters d’acide gras de PEG
• A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
• A61K 31/575 - Composés contenant des systèmes cycliques du cyclopenta[a]hydrophénanthrèneLeurs dérivés, p. ex. stéroïdes substitués en position 17 bêta par une chaîne d'au moins trois atomes de carbone, p. ex. cholane, cholestane, ergostérol, sitostérol

Abrégé

[Problem] To provide a novel face mask. [Solution] A face mask according to the present invention comprising a sheet-shaped base material configured so as to cover at least a part of the face of a user, and a cosmetic composition impregnated into the sheet-shaped base material, wherein: the sheet-shaped base material being provided with a nose cut section through which the nose of the user passes; a length L from the lowest part of the nose cut section to a lower side of the sheet-shaped base material is in a range of 80-100 mm; at the lower side of the sheet-shaped base material, the radius R1 of a curve of a portion intersecting a center perpendicular line of the sheet-shaped base material is in a range of 170-230 mm; and a stringing length of the cosmetic composition is 10 mm or more when the face mask is pulled and removed at a speed of 1200 mm/min.

Classes IPC  ?

• A61Q 19/00 - Préparations pour les soins de la peau
• A61K 8/02 - Cosmétiques ou préparations similaires pour la toilette caractérisés par une forme physique particulière
• A61K 8/34 - Alcools
• A61K 8/73 - Polysaccharides
• A45D 44/22 - Dispositifs pour modeler le visage, p. ex. mentonnièresInstruments pour effacer les rides, p. ex. par tension de la peau

Abrégé

The present invention relates to a laundry detergent composition, for preventing demineralization and color bleed, having improved activity for removing contaminants fixed into the fiber. Using the laundry detergent composition of the present invention allows contaminants fixed into the fiber, especially the contaminants that can easily get fixed in the lower-body undergarments of females due to bodily secretions, menstrual blood, and the like, can be completely removed without any residual contaminants.

Classes IPC  ?

• C11D 3/386 - Préparations contenant des enzymes
• C11D 3/20 - Composés organiques contenant de l'oxygène
• C11D 3/32 - AmidesAmides substituées
• C11D 3/16 - Composés organiques
• C11D 3/04 - Composés inorganiques solubles dans l'eau
• C11D 3/22 - Hydrates de carbone ou leurs dérivés
• C11D 3/33 - Acides aminocarboxyliques
• C11D 3/50 - Parfums
• C11D 3/00 - Autres composés entrant dans les compositions détergentes couvertes par le groupe

Produits et services

hair dryers; hair dryers for pets

Produits et services

hair dryers; hair dryers for pets.

Produits et services

Cosmetics and toiletries; soaps and detergents; skin whitening essences; skin whitening creams; skin lotions; cream for whitening the skin; cosmetic products for skin care; cosmetics used for skin; non-medicated skin care preparations; cleansing creams; skin washes; shampoos; essential oils; make-up powders; facial beauty masks; lipsticks; bath oils; dentifrices; mint essence (essential oil); perfumery; fragrances; incenses; hand creams. Medicated toiletry preparations; pharmaceutical preparations and substances used to improve freckles and improve chloasma; pharmaceutical preparations and substances used to treat skin containing tranexamic acid and cysteine and vitamin C; pharmaceutical preparations and substances; vitamin preparations and multi-vitamin preparations; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies; food for babies; lacteal flour for babies; oiled paper for medical purposes; wrapping wafers for medicine doses; empty capsules for pharmaceuticals; gauze for dressings; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton; adhesive plasters; bandages for dressings; liquid bandages; breast-nursing pads; dental materials, namely materials for stopping teeth, dental wax.

Produits et services

Cosmetics and toiletries; soaps and detergents; skin whitening essences; skin whitening creams; skin lotions; cream for whitening the skin; cosmetic products for skin care; cosmetics used for skin; non-medicated skin care preparations; cleansing creams; skin washes; shampoos; essential oils; make-up powders; facial beauty masks; lipsticks; bath oils; dentifrices; mint essence (essential oil); perfumery; fragrances; incenses; hand creams. Medicated toiletry preparations; pharmaceutical preparations and substances used to improve freckles and improve chloasma; pharmaceutical preparations and substances used to treat skin containing tranexamic acid and cysteine and vitamin C; pharmaceutical preparations and substances; vitamin preparations and multi-vitamin preparations; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies; food for babies; lacteal flour for babies; oiled paper for medical purposes; wrapping wafers for medicine doses; empty capsules for pharmaceuticals; gauze for dressings; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton; adhesive plasters; bandages for dressings; liquid bandages; breast-nursing pads; dental materials, namely materials for stopping teeth, dental wax.

Produits et services

Cosmetics and toiletries; soaps and detergents; skin whitening essences; skin whitening creams; skin lotions; cream for whitening the skin; cosmetic products for skin care; cosmetics used for skin; non-medicated skin care preparations; cleansing creams; skin washes; shampoos; essential oils; make-up powders; facial beauty masks; lipsticks; bath oils; dentifrices; mint essence (essential oil); perfumery; fragrances; incenses; hand creams. Medicated toiletry preparations; pharmaceutical preparations and substances used to improve freckles and improve chloasma; pharmaceutical preparations and substances used to treat skin containing tranexamic acid and cysteine and vitamin C; pharmaceutical preparations and substances; vitamin preparations and multi-vitamin preparations; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies; food for babies; lacteal flour for babies; oiled paper for medical purposes; wrapping wafers for medicine doses; empty capsules for pharmaceuticals; gauze for dressings; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton; adhesive plasters; bandages for dressings; liquid bandages; breast-nursing pads; dental materials, namely materials for stopping teeth, dental wax.

Abrégé

An intelligent factory energy management system for reducing production energy according to the present invention comprises: a power measurement and analysis device that receives voltage and current data measured by a voltage and current sensor, and calculates and analyzes power based thereon; an energy analysis device that analyzes a power consumption behavior on the basis of the power value and the analysis data calculated by the power measurement and analysis device; an energy management system that controls a power converter so as to reduce power consumption of a facility to be controlled and performs optimal energy saving using the energy consumption behavior data analyzed by the energy analysis device; and an integrated monitoring device that monitors the power status of each process in a plant, and power, voltage, current, and abnormalities of each distribution panel/switchboard and displays same on a screen in real time.

Classes IPC  ?

• G06Q 50/06 - Fourniture d’énergie ou d’eau
• G06Q 50/10 - Services
• G06Q 20/14 - Architectures de paiement spécialement adaptées aux systèmes de facturation

Produits et services

Dryer; hair dryer; hands free dryer; pet dryer; nail dryer; shoe dryer; hair care dryer; cloth dryer; pet hygiene dryer; brush dryer; hand dryer; dryer for baby; dryer with flexible hose.

Produits et services

Hair dryers

Abrégé

The present invention relates to a movable solar lighting apparatus that allows lighting to be turned on by means of electricity supplied using solar light in mountainous or remote areas or the like without a smooth supply of electricity, the apparatus comprising: a mounting frame having wheels; a post provided to stand vertically from the center of the top surface of the mounting frame; at least one lamp mounted on the upper part of the post; side frames provided on the left and right sides of the mounting frame; a solar panel coupled to the front of the side frames; and a shielding box provided on one side of the top surface of the mounting frame and having a charging battery, controller, inverter, etc. accommodated therein, thereby allowing the lamp to be turned on using electricity generated by the solar panel.

Classes IPC  ?

• F21S 9/03 - Dispositifs d'éclairage avec une source d'énergie incorporéeSystèmes utilisant des dispositifs d'éclairage avec une source d'énergie incorporée la source de courant étant une pile ou un accumulateur rechargeables par exposition à la lumière
• F21V 21/14 - Montages réglables

Abrégé

An infusion injection system wherein, when injecting a drug solution into a patient using an infusion set and an automatic infusion device, the automatic infusion device confirms various pieces of information regarding the infusion set in order to provide safe infusion for the patient, and to allow the user to assess the infusion information and manage a proper disposal procedure, wherein whether an infusion set is properly mounted is judged and if the judgment is positive, information stored in an IC tag attached to a drip tube 15 is read out by an IC tag reader unit 59 in an automatic infusion device 7, and information matching is verified between the read-out information and the information set beforehand for the automatic infusion device 7, and wherein control operations are performed only when the verification is a match.

Classes IPC  ?

• A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
• A61M 5/14 - Dispositifs de perfusion, p. ex. perfusion par gravitéPerfusion sanguineAccessoires à cet effet
• A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte

Abrégé

Provided is an infusion injection system, the purpose of which, when injecting a drug solution into a patient using an infusion set and an automatic infusion device, is: to confirm various pieces of information of the infusion set using the automatic infusion device; to safely give an infusion to a patient; and to make it possible to confirm the steps up to the obtaining of infusion information and the proper management of disposal of the infusion set. Whether an infusion set is properly mounted is determined in a step (step 62); if the determination is positive, information in an IC tag attached to a drip tube 15 is read out by an IC tag reader unit 59 provided in an automatic infusion device 7; and the information is verified against information set in advance in the automatic infusion device 7 as illustrated in a step (step 65). Control is performed to execute processing of and after a step (step 7) only if the result of the verification is a match.

Classes IPC  ?

• A61M 5/172 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte électriques ou électroniques
• A61M 5/14 - Dispositifs de perfusion, p. ex. perfusion par gravitéPerfusion sanguineAccessoires à cet effet
• A61M 5/168 - Moyens pour commander l'écoulement des agents vers le corps ou pour doser les agents à introduire dans le corps, p. ex. compteurs de goutte-à-goutte

Abrégé

The present invention provides an optical pickup device carrying out a focusing servo by applying an ASP disposed to be inclined to an optical system of the optical pickup device so as to generate astigmatism, and having an improved structure in which a BD optical system carries out a tracking servo with a 1-beam method while removing a grating optical component between a light source and a beam splitter.

Classes IPC  ?

• G11B 7/1381 - Éléments, autres que des lentilles, pour modifier les propriétés du faisceau, p. ex. lames de couteau, fentes, filtres ou bloqueurs

Produits et services

Cosmetics and toiletries; soaps and detergents; skin whitening essences; skin whitening creams; skin lotions; cream for whitening the skin; cosmetic products for skin care; cosmetics used for skin; non-medicated skin care preparations; cleansing creams; skin washes; shampoos; essential oils; make-up powders; facial beauty masks; lipsticks; bath oils; dentifrices; mint essence (essential oil); perfumery; fragrances; incenses; hand creams. Pharmaceutical preparations and substances; pharmaceutical preparations and substances used to improve freckles and improve chloasma; pharmaceutical preparations and substances used to treat skin containing tranexamic acid and cystein and vitamin c; vitamin preparations and multi-vitamin preparations; dietary supplements for humans; dietetic beverages adapted for medical purposes, dietetic food adapted for medical purposes; beverages for babies, food for babies; lacteal flour for babies; oiled paper for medical purposes, wrapping wafers for medicine doses, empty capsules for pharmaceuticals, gauze for dressings, eyepatches for medical purposes, ear bandages, menstruation bandages, menstruation tampons, sanitary napkins, sanitary panties, absorbent cotton, adhesive plasters, bandages for dressings, liquid bandages, breast-nursing pads; dental materials, namely materials for stopping teeth, dental wax.

Produits et services

Cosmetics and toiletries; soaps and detergents; skin whitening essences; skin whitening creams; skin lotions; cream for whitening the skin; cosmetic products for skin care; cosmetics used for skin; non-medicated skin care preparations; cleansing creams; skin washes; shampoos; essential oils; make-up powders; facial beauty masks; lipsticks; bath oils; dentifrices; mint essence (essential oil); perfumery; fragrances; incenses; hand creams. Pharmaceutical preparations and substances; pharmaceutical preparations and substances used to improve freckles and improve chloasma; pharmaceutical preparations and substances used to treat skin containing tranexamic acid and cystein and vitamin C; vitamin preparations and multi-vitamin preparations; dietary supplements for humans; dietetic beverages adapted for medical purposes, dietetic food adapted for medical purposes; beverages for babies, food for babies; lacteal flour for babies; oiled paper for medical purposes, wrapping wafers for medicine doses, empty capsules for pharmaceuticals, gauze for dressings, eyepatches for medical purposes, ear bandages, menstruation bandages, menstruation tampons, sanitary napkins, sanitary panties, absorbent cotton, adhesive plasters, bandages for dressings, liquid bandages, breast-nursing pads; dental materials, namely materials for stopping teeth, dental wax.

Produits et services

Hair care preparations; hair treatment preparations; hair tonics; hair spray; hair lotions; hair dyes; hair oils; permanent wave preparations; hair bleaches; hair colorants; shampoos; soaps and detergents; dentifrices; cosmetics; cosmetic kits; toiletries; perfumes; essential oils; peppermint oil [perfumery]; medicated soap; cosmetic preparations for eyelashes; eyebrow cosmetics. Medicinal hair growth preparations; pharmaceutical preparations and substances; medicines for human purposes; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; oiled paper for medical purposes; wrapping wafers for medicine doses; gauze for dressings; capsules for pharmaceutical purposes; eyepatches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton; adhesive plasters; bandages for dressings; liquid dressings; breast-nursing pads; dental materials; lacteal flour for babies; dietary supplements for humans; dietetic beverages adapted for medical purposes; dietetic food adapted for medical purposes; beverages for babies; food for babies.

Produits et services

Pharmaceutical preparations and substances; medicines for human purposes; pharmaceutical preparations and other preparations for destroying vermin, fungicides, herbicides; oiled paper for medical purposes; wrapping wafers for medicine doses; gauze for dressings; capsules for pharmaceutical purposes; eye patches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton; adhesive plasters; bandages for dressings; liquid dressings; breast-nursing pads; dental materials.

Produits et services

Pharmaceutical preparations and substances (except for mosquito-repellent incenses, sodium salts for medical purposes and medicinal alcoholic beverages); medicines for human purposes; adhesive plasters; bandages for dressings; liquid dressings; gauze for dressings; pledget, namely wisp of cotton thread and yearn, for medical purposes; absorbent wadding; wrapping wafers for medicine doses; sponges for medical purposes; capsules for pharmaceutical purposes; menstruation bandages; lactose for preparing pharmaceutical and veterinary preparations; fungicides, herbicides.

Produits et services

Soap; disinfectant soap; cleansing milk for toilet purposes; medicated soap; hair cleaners; soap for foot perspiration; deodorant soap; cakes of toilet soap; cakes of soap; antiperspirant soap (sweat prevention); antiperspirant soap (sweat removal); hand soap; shampoos; shampoo soft soap; hair softener; hair conditioner; antimicrobial hand soap; body shampoo; facial cleansing creams; skin whitening creams; hair dyes; cosmetics; facial washing milk; moisturizing face masks.

Produits et services

Dentifrices and mouthwashes; tooth powder; moistened tooth powder; non-medicated dental rinse; dentifrices in the form of chewing gum; tooth paste.

Abrégé

The present invention relates to a prostate cancer diagnosis device including a semiconductor laser emitting a laser beam; an optical unit transmitting the laser beam to a prostate sample and receiving auto-fluorescence generated from the prostate sample; a detection unit detecting the auto-fluorescence received by the optical unit and measuring intensity of a single photon corresponding to a single pulse to detect intensity of the time-dependent auto-fluorescence (hereinafter referred to as an auto-fluorescence measured value); and a diagnosis unit calculating fractal dimension values DF of the auto-fluorescence measured value using a fractal dimension algorithm, and a prostate cancer diagnosis method using the same.

Classes IPC  ?

• G01N 33/52 - Utilisation de composés ou de compositions pour des recherches colorimétriques, spectrophotométriques ou fluorométriques, p. ex. utilisation de bandes de papier indicateur
• G01N 21/64 - FluorescencePhosphorescence
• G01N 33/68 - Analyse chimique de matériau biologique, p. ex. de sang ou d'urineTest par des méthodes faisant intervenir la formation de liaisons biospécifiques par ligandsTest immunologique faisant intervenir des protéines, peptides ou amino-acides

Abrégé

The present invention relates to a prostate cancer diagnosis device including a semiconductor laser emitting an laser beam; an endoscope transmitting the laser beam to a biopsy tissue in a human body and receiving auto-fluorescence generated from the biopsy tissue; an optical unit transmitting the laser beam to the endoscope and receiving an auto-fluorescence generated from the biopsy tissue from the endoscope; a detection unit detecting the auto-fluorescence received by the optical unit and measuring intensity of a single photon corresponding to a single pulse to detect intensity of the time-dependent auto-fluorescence (hereinafter referred to as an auto-fluorescence measured value); and a diagnosis unit calculating fractal dimension values of the auto-fluorescence measured value using a fractal dimension algorithm, and a diagnosis method using the same.

Classes IPC  ?

• A61B 5/06 - Dispositifs autres que ceux à radiation, pour détecter ou localiser les corps étrangers
• A61B 5/0275 - Mesure du débit sanguin utilisant des marqueurs, p. ex. dilution de colorant

Abrégé

A therapeutic or prophylactic agent for influenza infection, the function mechanism of which is to effectively overcome ATP depletion, said agent comprising diisopropylamine dichloroacetate (DADA), DADA and gluconic acid or a salt thereof, or DADA, gluconic acid or a salt thereof and a vitamin B1 compound.

Classes IPC  ?

• A61K 31/131 - Amines, p. ex. amantadine acycliques
• A61K 31/19 - Acides carboxyliques, p. ex. acide valproïque
• A61K 31/52 - Purines, p. ex. adénine
• A61K 31/7012 - Composés ayant un groupe carboxyle libre ou estérifié, lié directement ou par une chaîne carbonée, à un atome de carbone du radical saccharide, p. ex. acide glucuronique, acide neuraminique
• A61P 31/16 - Antiviraux pour le traitement des virus ARN de la grippe ou des rhinovirus
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Abrégé

Disclosed is a tablet containing tranexamic acid, ascorbic acid and L-cysteine, which has excellent stability and is suppressed in discoloration and unpleasant odor. Specifically disclosed is a film-coated tablet that is obtained by providing a tablet, which contains tranexamic acid, ascorbic acid and L-cysteine, with a coating film that contains a polyvinyl alcohol copolymer.

Classes IPC  ?

• A61K 31/375 - Acide ascorbique, c.-à-d. vitamine CSes sels
• A61K 9/30 - Revêtements organiques
• A61K 31/195 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques

Abrégé

Provided is a solid pharmaceutical formulation for internal use, having no discoloration and excellent stability, with a formulation that contains tranexamic acid and ascorbic acid. The solid pharmaceutical formulation for internal use is characterized in that the formulation is comprised by adding a polyvinyl alcohol copolymer and/or partially saponified polyvinyl alcohol to the formulation that contains tranexamic acid and ascorbic acid.

Classes IPC  ?

• A61K 31/375 - Acide ascorbique, c.-à-d. vitamine CSes sels
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/32 - Revêtements organiques contenant des polymères synthétiques solides
• A61K 31/195 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino
• A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 31/4415 - Pyridoxine, c.-à-d. vitamine B6
• A61K 47/32 - Composés macromoléculaires obtenus par des réactions faisant intervenir uniquement des liaisons non saturées carbone-carbone, p. ex. carbomères
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques

Abrégé

Disclosed is a solid preparation for oral administration, which comprises tranexamic acid and ascorbic acid, does not undergo discoloration or the like, and therefore meets the requirements for stability. Specifically disclosed is a solid preparation for oral administration, which is characterized by comprising tranexamic acid and ascorbic acid as active ingredients, wherein the active ingredients are separated from each other through a boundary.

Classes IPC  ?

• A61K 31/375 - Acide ascorbique, c.-à-d. vitamine CSes sels
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/28 - DragéesPilules ou comprimés avec revêtements
• A61K 9/30 - Revêtements organiques
• A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
• A61K 31/195 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino
• A61K 31/197 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino les groupes amino et carboxyle étant liés à la même chaîne carbone acyclique, p. ex. acide gamma-aminobutyrique [GABA], bêta-alanine, acide epsilon-aminocaproïque ou acide pantothénique
• A61K 31/198 - Alpha-amino-acides, p. ex. alanine ou acide édétique [EDTA]
• A61K 31/4415 - Pyridoxine, c.-à-d. vitamine B6
• A61P 17/02 - Médicaments pour le traitement des troubles dermatologiques pour traiter les blessures, les ulcères, les brûlures, les cicatrices, les cheloïdes, ou similaires

Abrégé

Disclosed is a pharmaceutical composition which is stable and free from discoloration or the like even when tranexamic acid and ascorbic acid are uniformly mixed therein. The pharmaceutical composition containing tranexamic acid and ascorbic acid is characterized in that an organic acid or an antioxidant other than ascorbic acid and tocopherol is additionally contained therein as a stabilizer, and that the components contained in the composition are uniformly mixed therein.

Classes IPC  ?

• A61K 31/375 - Acide ascorbique, c.-à-d. vitamine CSes sels
• A61K 9/16 - AgglomérésGranulésMicrobilles
• A61K 9/20 - Pilules, pastilles ou comprimés
• A61K 9/28 - DragéesPilules ou comprimés avec revêtements
• A61K 9/48 - Préparations en capsules, p. ex. de gélatine, de chocolat
• A61K 9/50 - Microcapsules
• A61K 31/195 - Acides carboxyliques, p. ex. acide valproïque ayant un groupe amino
• A61K 47/02 - Composés inorganiques
• A61K 47/12 - Acides carboxyliquesLeurs sels ou anhydrides
• A61K 47/22 - Composés hétérocycliques, p. ex. acide ascorbique, tocophérol ou pyrrolidones
• A61P 17/00 - Médicaments pour le traitement des troubles dermatologiques

Abrégé

The present invention provides a digitizer for a fingertip tactile-sense input device to which switches can be added without having to increase the number of wires. A first lower right contact (33b) and a second lower right contact (33c) are placed respectively on the first and second resistive sheets (10a, 20a) at specified positions that are separated to the right from the control area (11, 21) so that they form a lower right switch (33), with the first lower right contact (33b) being connected to the bottom edge electrode (11b) and the second lower right contact (33c) being connected to the right edge electrode (21a); and a first upper left contact (34b) and a second upper left contact (34c) are placed respectively on the first and second resistive sheets (10a, 20a) at specified positions that are separated to the left from the control area (11, 21) so that they form the upper left switch (34), with the first upper left contact (34b) being connected to the top edge electrode (11a) and the second upper left contact (34c) being connected to the left edge electrode 21b.

Classes IPC  ?

• G06F 3/045 - Numériseurs, p. ex. pour des écrans ou des pavés tactiles, caractérisés par les moyens de transduction utilisant des éléments résistifs, p. ex. une seule surface uniforme ou deux surfaces parallèles mises en contact

Abrégé

To provide a fingertip tactile-sense input device in an input device having a plurality of keys within an extremely small range such as within a range of person's fingertip movement, which while being made extremely small and thin, enables key input while maintaining a sufficient click feeling, and also which is excellent for mass production. A base plate (50) has one dome spring (51) arranged at an approximate center of a side of a hole space, and a contact structure (52) on an inside of the dome spring (51). A surface sheet (20) is fixed to a flange (11) so that in a free state, this becomes approximately the same level as an other face of a frame (10), and is provided with a plurality of surface protrusions (21) deployed within a range in which the person's fingertip moves, and has flexibility, elasticity, and pliability. A digitizer (30) is arranged on the hole space side of the surface sheet (20), so as to be slidable on the surface sheet (20), and is capable of electrically measuring a position where a force applied to the surface sheet (20) is the strongest. A convex part (41) is provided on an actuator (40), and the actuator (40) is fixed to the digitizer (30), and has rigidity.

Classes IPC  ?

• G06F 3/033 - Dispositifs de pointage déplacés ou positionnés par l'utilisateurLeurs accessoires

Abrégé

A probe unit and a needle thereof are disclosed. The needle of the probe unit includes: a beam fixedly coupled to a needle guide; a probe portion for electrically touching a pad formed on an LCD panel. The probe portion is located under the beam, spaced apart from the beam at a certain distance within which the rise in height of the probe portion is limited by the beam. The needle includes a connection portion formed such that the probe portion can be connected to the beam, for exerting an elastic restoring force on the probe portion when the probe portion rises. The needle does not undergo an excessive deformation, and a plurality of needles do not mutually interfere. The life span of the probe unit can be extended.

Classes IPC  ?

• G01R 1/067 - Sondes de mesure

Abrégé

A probe card for use in the test of the semiconductor devices, a needle of the probe card, and a method of manufacturing the needle are disclosed. This invention is to strengthen the beam portion of the needle, to reduce the contact area between a probing portion and a pad of a wafer die, and to prevent the test apparatus from malfunctioning. The needle of a probe card includes: a probing portion for contacting a pad of a wafer die at a certain pin pressure; a soldered portion soldered to a circuit board of the probe card, for transmitting an electrical signal to the probing portion; and a beam portion integrally connecting the probing portion and the soldered portion and having elasticity to exhibit a certain pin pressure by which the probing portion 210 can elastically contact the pad of a wafer die. Here, the beam portion has undergone a plating process. The needle of a probe card can precisely contact the pad.

Classes IPC  ?

• G01R 1/067 - Sondes de mesure

Abrégé

A needle of probe card and a fabrication method thereof are provided. The needle of probe card includes a post part, a beam part, a tip part and a wall part, with a monolithically formed type, for enhancing an exact and reliable characteristic test and a durability of the needle and for fabricating needles more simply. The post part has a given height, and a lower end part of the post part is combined with a terminal of a substrate. One end of the beam part is combined with one side part of an upper part of the post part, and another end thereof extended horizontally is formed with a vertical bending characteristic. The tip part is formed being protruded up from another end corresponding to the one end of the beam part, and a top portion of the tip part has a tip shape. The wall part is formed in a shape of having a constant gap from both side faces of the beam part combined with the post in a paralleled shape so as to control a side-directional motion of the beam part in a type of covering both side faces of the beam part with keeping the constant gap.

Classes IPC  ?

• H01L 21/66 - Test ou mesure durant la fabrication ou le traitement

Produits et services

Non-medicated skin care preparations, namely, cleansing gels; washing foams; moisture lotions; skin moisturizer; moisture creams; shampoos; conditioners; body soaps; sunscreen preparations; make-up bases; [ liquid foundation; loose face powder; ] [ facial soaps; ] skin lotions; cosmetic preparations for treatment of oily skin; face milk; cosmetic gels for acne

Produits et services

Cleansing gels; washing foams; moisture lotions; moisture essence; moisture creams; shampoos; conditioners; body soaps; skin creams; sunscreen preparations; make-up bases; liquid foundation; loose face powder; facial soaps; skin lotions; oil control essence; milky lotions; cosmetic gels for acne; bleaching preparations and other substances for laundry use; cleaning, polishing, scouring and abrasive preparations; soaps; perfumery, essential oils, cosmetics, hair lotions; dentifrices.

Produits et services

(1) Cleansing gels; washing foams for skin; moisture lotions for skin for cosmetic purposes; skin moisturizer in the form of viscous liquid; moisture cream for skin for cosmetic purposes; sunscreen preparations; cosmetic preparations for treatment of oily skin; milky lotions for skin for cosmetic purposes.

Produits et services

Pharmaceutical, veterinary and sanitary preparations; preparations for destroying vermin; fungicides; herbicides; oiled paper for medical purposes; sanitary masks; pharmaceutical wafer; gauze for dressings; empty capsules for pharmaceuticals; eye patches for medical purposes; ear bandages; menstruation bandages; menstruation tampons; sanitary napkins; sanitary panties; absorbent cotton; adhesive plasters; bandages for dressings; collodion for pharmaceutical purposes; breast-nursing pads; dental materials; bracelets for medical purposes; incontinence diapers; mothproofing paper; lactose (milk sugar).

Abrégé

An antitussive or expectorant pharmaceutical composition comprising loxoprofen and one or more members selected from caffeine, ephedrine and codeine.

Classes IPC  ?

• A61K 31/522 - Purines, p. ex. adénine ayant des groupes oxo liés directement à l'hétérocycle, p. ex. hypoxanthine, guanine, acyclovir
• A61K 31/137 - Arylalkylamines, p. ex. amphétamine, épinéphrine, salbutamol, éphédrine
• A61K 31/192 - Acides carboxyliques, p. ex. acide valproïque ayant des groupes aromatiques, p. ex. sulindac, acides 2-aryl-propioniques, acide éthacrynique
• A61K 31/485 - Dérivés du morphinane, p. ex. morphine, codéine
• A61P 11/00 - Médicaments pour le traitement des troubles du système respiratoire
• A61P 11/06 - Antiasthmatiques
• A61P 11/10 - Expectorants
• A61P 11/14 - Antitussifs
• A61P 31/06 - Agents antibactériens pour le traitement de la tuberculose
• A61P 43/00 - Médicaments pour des utilisations spécifiques, non prévus dans les groupes

Produits et services

(1) Cleansing gels; washing foams; moisture lotions; moisture essence; moisture creams; shampoos; conditioners; body soaps; skin creams; sunscreen preparations; make-up bases; liquid foundation.

Produits et services

Cleansing gels, washing foams, facial soaps, moisture lotions, moisture essence, moisture creams, shampoos, conditioners, body soaps, bath essence, skin creams.